IgGenix Announces Jessica Grossman, M.D., as Chief Executive Officer

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--IgGenix, Inc., a biotechnology company taking a revolutionary approach to directly address allergic disease, announced that Jessica Grossman, M.D., has joined IgGenix as chief executive officer (CEO). Dr. Grossman has over two decades of experience in the medical, pharmaceutical and biotechnology fields. Dr. Grossman has dedicated...

Click to view original post